The American journal of Chinese medicine Pub Date : 2024-01-01 Epub Date: 2024-11-30 DOI:10.1142/S0192415X24500800
Mengmeng Zhang, Xu Wu, Huanqing Gao, Lin Zhang, Yao Li, Min Li, Chongbo Zhao, Peifeng Wei, Li Ou
{"title":"Chinese Herbal Medicine for Irritable Bowel Syndrome: A Perspective of Local Immune Actions.","authors":"Mengmeng Zhang, Xu Wu, Huanqing Gao, Lin Zhang, Yao Li, Min Li, Chongbo Zhao, Peifeng Wei, Li Ou","doi":"10.1142/S0192415X24500800","DOIUrl":null,"url":null,"abstract":"<p><p>Irritable bowel syndrome (IBS) is the functional gastrointestinal disorder, characterized by abdominal pain and altered bowel habits. The interest in intestinal immune activation as a potential disease mechanism for IBS has increased exponentially in recent years. This study was designed to summarize the Chinese herbal medicine (CHM) that potentially exert protective effects against IBS through inhibition of intestinal immune activation. We detailed the current evidence that immune activation contributes to the pathology of IBS and discussed the potential mechanisms involved. Then, therapeutic effects and possible mechanisms related to immune response of herbal medicine prescriptions, extracts, and monomers were analyzed. The reasons leading to the aberrant and persistent immune activation noted in IBS are mainly associated with the increased number of mast cells, CD3[Formula: see text] T cells, and CD4[Formula: see text] T cells. The mechanisms mainly focused on the gut microbiota disorder induced alteration of the PGE2/COX2/SERT/5-HT, TLR4/MyD88/NF-κB, and BDNF/TrkB pathways. Most of the CHM alleviated IBS through interventions of intestinal immune activation via gut microbiota related to the TLR4/MyD88/NF-κB and SCF/c-kit pathways. We hope this review will provide some clues for the further development of novel candidate agents for IBS and other intestinal immune disorders.</p>","PeriodicalId":94221,"journal":{"name":"The American journal of Chinese medicine","volume":"52 7","pages":"2079-2106"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American journal of Chinese medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1142/S0192415X24500800","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

肠易激综合征(IBS)是一种功能性胃肠道疾病,以腹痛和排便习惯改变为特征。近年来,人们对肠道免疫激活作为肠易激综合征潜在疾病机制的兴趣急剧增加。本研究旨在总结可能通过抑制肠道免疫激活而对肠易激综合征产生保护作用的中草药。我们详细介绍了免疫激活导致肠易激综合征病理的现有证据,并讨论了其中的潜在机制。然后,分析了中药处方、提取物和单体的治疗效果以及与免疫反应相关的可能机制。导致肠易激综合征出现异常和持续免疫激活的原因主要与肥大细胞、CD3[方见正文] T细胞和CD4[方见正文] T细胞数量增加有关。其机制主要集中于肠道微生物群紊乱引起的 PGE2/COX2/SERT/5-HT、TLR4/MyD88/NF-κB 和 BDNF/TrkB 通路的改变。大多数肠道微生物疗法通过与 TLR4/MyD88/NF-κB 和 SCF/c-kit 通路相关的肠道微生物群干预肠道免疫激活,从而缓解肠易激综合征。我们希望这篇综述能为进一步开发治疗肠易激综合征和其他肠道免疫疾病的新型候选药物提供一些线索。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Chinese Herbal Medicine for Irritable Bowel Syndrome: A Perspective of Local Immune Actions.

Irritable bowel syndrome (IBS) is the functional gastrointestinal disorder, characterized by abdominal pain and altered bowel habits. The interest in intestinal immune activation as a potential disease mechanism for IBS has increased exponentially in recent years. This study was designed to summarize the Chinese herbal medicine (CHM) that potentially exert protective effects against IBS through inhibition of intestinal immune activation. We detailed the current evidence that immune activation contributes to the pathology of IBS and discussed the potential mechanisms involved. Then, therapeutic effects and possible mechanisms related to immune response of herbal medicine prescriptions, extracts, and monomers were analyzed. The reasons leading to the aberrant and persistent immune activation noted in IBS are mainly associated with the increased number of mast cells, CD3[Formula: see text] T cells, and CD4[Formula: see text] T cells. The mechanisms mainly focused on the gut microbiota disorder induced alteration of the PGE2/COX2/SERT/5-HT, TLR4/MyD88/NF-κB, and BDNF/TrkB pathways. Most of the CHM alleviated IBS through interventions of intestinal immune activation via gut microbiota related to the TLR4/MyD88/NF-κB and SCF/c-kit pathways. We hope this review will provide some clues for the further development of novel candidate agents for IBS and other intestinal immune disorders.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信